Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (281-290 of 368) with videos related to

Pageof 37
Sort By:
Transplantation Proceedings|August 21, 2021
First-Line Unrelated Double-Unit Umbilical Cord Blood Transplantation for Acquired Severe Aplastic AnemiaQiurong Liu, Yanming Zhang, Huifen Zhou, et al.
Hematological Oncology|February 1, 2021
Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemiaTongyan Meng, Jiaqian Qi, Yuanxin Zhu, et al.
Frontiers in Oncology|August 1, 2022
Recurrent Novel <i>P2RY8/IGH</i> Translocations in B-Lymphoblastic Leukemia/LymphomaYanglan Fang, Man Wang, Shuhong Hu, et al.
Cancer|November 26, 2024
Patient-reported outcomes in adults with tyrosine kinase inhibitor-resistant chronic myeloid leukemia receiving olverembatinib therapyLu Yu, Weiming Li, Na Xu, et al.
Journal of Hematology & Oncology|October 12, 2024
Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantationXin Kong, Ziyi Xu, Yanjun Wu, et al.
British Journal of Haematology|November 12, 2025
The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapyLinghao Li, Zihao Wang, Chongsheng Qian, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 10, 2017
A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short reportSuning Chen, Stefan Nagel, Bjoern Schneider, et al.
Blood Cancer Journal|May 10, 2023
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 monthsZhenzhen Yao, Bin Gu, Jia Chen, et al.
Leukemia Research|June 19, 2014
Rapamycin inhibits pre-B acute lymphoblastic leukemia cells by downregulating DNA and RNA polymerasesZhijian Wang, Fei Xu, Na Yuan, et al.
Annals of Hematology|August 1, 2020
Identification of a novel ETV6 truncated fusion gene in myeloproliferative neoplasm, unclassifiable with t(4;12)(q12;p13)Ling Zhang, Man Wang, Zheng Wang, et al.
Pageof 37

Showing results (281-290 of 368) with videos related to

Sort By:
Pageof 37
Transplantation Proceedings|August 21, 2021
First-Line Unrelated Double-Unit Umbilical Cord Blood Transplantation for Acquired Severe Aplastic AnemiaQiurong Liu, Yanming Zhang, Huifen Zhou, et al.
Hematological Oncology|February 1, 2021
Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemiaTongyan Meng, Jiaqian Qi, Yuanxin Zhu, et al.
Frontiers in Oncology|August 1, 2022
Recurrent Novel <i>P2RY8/IGH</i> Translocations in B-Lymphoblastic Leukemia/LymphomaYanglan Fang, Man Wang, Shuhong Hu, et al.
Cancer|November 26, 2024
Patient-reported outcomes in adults with tyrosine kinase inhibitor-resistant chronic myeloid leukemia receiving olverembatinib therapyLu Yu, Weiming Li, Na Xu, et al.
Journal of Hematology & Oncology|October 12, 2024
Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantationXin Kong, Ziyi Xu, Yanjun Wu, et al.
British Journal of Haematology|November 12, 2025
The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapyLinghao Li, Zihao Wang, Chongsheng Qian, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 10, 2017
A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short reportSuning Chen, Stefan Nagel, Bjoern Schneider, et al.
Blood Cancer Journal|May 10, 2023
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 monthsZhenzhen Yao, Bin Gu, Jia Chen, et al.
Leukemia Research|June 19, 2014
Rapamycin inhibits pre-B acute lymphoblastic leukemia cells by downregulating DNA and RNA polymerasesZhijian Wang, Fei Xu, Na Yuan, et al.
Annals of Hematology|August 1, 2020
Identification of a novel ETV6 truncated fusion gene in myeloproliferative neoplasm, unclassifiable with t(4;12)(q12;p13)Ling Zhang, Man Wang, Zheng Wang, et al.
Pageof 37